These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18479485)

  • 21. Evaluating candidate principal surrogate endpoints.
    Gilbert PB; Hudgens MG
    Biometrics; 2008 Dec; 64(4):1146-54. PubMed ID: 18363776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analyzing spatially distributed binary data using independent-block estimating equations.
    Oman SD; Landsman V; Carmel Y; Kadmon R
    Biometrics; 2007 Sep; 63(3):892-900. PubMed ID: 17489971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statistical inference for a two-stage outcome-dependent sampling design with a continuous outcome.
    Zhou H; Song R; Wu Y; Qin J
    Biometrics; 2011 Mar; 67(1):194-202. PubMed ID: 20560938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing biomarkers as principal surrogate endpoints.
    Huang Y; Gilbert PB
    Biometrics; 2011 Dec; 67(4):1442-51. PubMed ID: 21517791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Semiparametric efficient estimation in the generalized odds-rate class of regression models for right-censored time-to-event data.
    Scharfstein DO; Tsiatis AA; Gilbert PB
    Lifetime Data Anal; 1998; 4(4):355-91. PubMed ID: 9880995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient data integration under prior probability shift.
    Huang MY; Qin J; Huang CY
    Biometrics; 2024 Mar; 80(2):. PubMed ID: 38768225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Empirical Likelihood in Nonignorable Covariate-Missing Data Problems.
    Xie Y; Zhang B
    Int J Biostat; 2017 Apr; 13(1):. PubMed ID: 28441139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Likelihood methods for treatment noncompliance and subsequent nonresponse in randomized trials.
    O'Malley AJ; Normand SL
    Biometrics; 2005 Jun; 61(2):325-34. PubMed ID: 16011678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Case-only analysis of treatment-covariate interactions in clinical trials.
    Vittinghoff E; Bauer DC
    Biometrics; 2006 Sep; 62(3):769-76. PubMed ID: 16984319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating principal surrogate markers in vaccine trials in the presence of multiphase sampling.
    Huang Y
    Biometrics; 2018 Mar; 74(1):27-39. PubMed ID: 28653408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regularized estimation in the accelerated failure time model with high-dimensional covariates.
    Huang J; Ma S; Xie H
    Biometrics; 2006 Sep; 62(3):813-20. PubMed ID: 16984324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increasing power in randomized trials with right censored outcomes through covariate adjustment.
    Moore KL; van der Laan MJ
    J Biopharm Stat; 2009 Nov; 19(6):1099-131. PubMed ID: 20183467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Machine learning methods for leveraging baseline covariate information to improve the efficiency of clinical trials.
    Zhang Z; Ma S
    Stat Med; 2019 May; 38(10):1703-1714. PubMed ID: 30474289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Semiparametric transformation models for multiple continuous biomarkers in ROC analysis.
    Kim E; Zeng D; Zhou XH
    Biom J; 2015 Sep; 57(5):808-33. PubMed ID: 26138227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A semiparametric empirical likelihood method for data from an outcome-dependent sampling scheme with a continuous outcome.
    Zhou H; Weaver MA; Qin J; Longnecker MP; Wang MC
    Biometrics; 2002 Jun; 58(2):413-21. PubMed ID: 12071415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Simulation-Based Comparison of Covariate Adjustment Methods for the Analysis of Randomized Controlled Trials.
    Chaussé P; Liu J; Luta G
    Int J Environ Res Public Health; 2016 Apr; 13(4):414. PubMed ID: 27077870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Semiparametric regression of multidimensional genetic pathway data: least-squares kernel machines and linear mixed models.
    Liu D; Lin X; Ghosh D
    Biometrics; 2007 Dec; 63(4):1079-88. PubMed ID: 18078480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimation of the optimal surrogate based on a randomized trial.
    Price BL; Gilbert PB; van der Laan MJ
    Biometrics; 2018 Dec; 74(4):1271-1281. PubMed ID: 29701875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meta-analysis of gene-environment interaction exploiting gene-environment independence across multiple case-control studies.
    Estes JP; Rice JD; Li S; Stringham HM; Boehnke M; Mukherjee B
    Stat Med; 2017 Oct; 36(24):3895-3909. PubMed ID: 28744888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Joint analysis of longitudinal data with informative right censoring.
    Liu M; Ying Z
    Biometrics; 2007 Jun; 63(2):363-71. PubMed ID: 17425632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.